Navigation Links
Sciedu Press Support the New Open Access Policy of Canadian Institutes of Health Research
Date:11/14/2013

TORONTO, Nov. 14, 2013 /PRNewswire-iReach/ -- A Canadian based company, Sciedu Press (Linkedin) is an open access scholarly journal publisher that deals with all scientific research. Their main expertise lies in the field of education, culture and biological as well as social sciences. Their basic aim is to spread awareness and give scope to all writers who want to publish their research that is based on facts and figures, authenticating any subject and/or topic.

(Photo:  http://photos.prnewswire.com/prnh/20131114/MN16665)

The dedication and passion of Sciedu Press can be validated by the idea that even their name implies their work. Sciedu is a short formed combination of science and education. This shows that they firmly believe in educating the masses scientifically.

They also sponsor as well as support research projects, international networks and corporation in science, education and culture.  

Since its conception in 2000, under the authority of Canadian Institutes of Health and Research Act, Canadian Institutes of Health and Research has been working to improve the health services and products provided to all citizens. Their aim is advance, promote and build up the strength of the Canadian health system.

CIHR is basically an independent health research investment agency that is made up of 13 institutes and is answerable to the Parliament. They provide assistance and support to more than 14,100 trainees and health researchers throughout Canada. They are closely associated with the Minster of Health to ensure the fitness and wellness of all the Canadians.  

The first question that comes to mind is what is open access policy? It is a policy that supports the publication and accessibility of research by international research community, increasing the research result's application in open domain. What this is basically does is that it increases reliability, trustworthiness and a general sense of 'no hiding' or shady research.

Since Canadian Institutes of Health Research is an organization dependent upon public funds, their purpose is to let a huge audience be able to access all research publications. This barrier less approach ensures that public health research improves thereby improving medical conditions across the country. With the help of internet, this task has not only been made easier, it has also been made interactive.

The Open Access Policy commits to freedom of academics for one and all. And this is why Sciedu Press is a huge supporter. They agree with the concept of spreading research publication as widely as possible, so that everyone can have access to it. It would create an effective diffusion of results generated by research.    

Sciedu Press has been working hard in the research publishing community to create awareness and show support of promoting widespread scientific research and education. They believe that nothing is more important that allowing everyone to be on equal footing when it comes to education, the availability and accessibility of research material. For them, the utmost importance is of their user experience and they want to bring scientific research to the hands of the masses.    

 

Media Contact: Evan Ballmer, Sciedu Press, +1 416-479-0028, webtech8899@gmail.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE Sciedu Press
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Sciedu Press Supports Open Access Journal Publishing
2. Sciedu Press Launches New Journal for Management and Orgnaization Studies
3. How Sciedu Press Has Taken the Initiative to Sponsor Scholartools.org
4. Nations Best Health Care Organizations for Patient Satisfaction, Core Measures Honored by Press Ganey
5. Compressus Drives Programmable Workflow And Unprecedented Flexibility With Introduction of MEDxConnect™ v4.0
6. Breast Cancer Vaccine Being Developed by Generex Subsidiary Antigen Express to be Featured on Bloomberg Television Today
7. Generex Subsidiary Antigen Express Provides Update on AE37 Cancer Vaccines Clinical & Regulatory Strategy
8. Veracyte Announces Medicare Coverage for Its Afirma® Gene Expression Classifier for Improved Thyroid Nodule Diagnosis
9. Live Press Briefing on Findings of Biomedical Industry CEO Survey
10. Neuralstem President and CEO to Update Ongoing ALS and NSI-189/Major Depressive Disorder Trials at 2012 Biotech Showcase
11. Valkee and University of Oulu Publish the First Clinical Trial on Bright Light Therapy Channeled via ear Canals in Seasonal Depression
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... , Feb. 4, 2016  Spherix Incorporated (Nasdaq: ... fostering and monetization of intellectual property, today provided an ... in the Northern District of Texas ... Inter Partes Re-examination ("IPR") proceedings ... Office.  The IPR was initiated on only certain claims ...
(Date:2/3/2016)... SAN DIEGO , Feb. 3, 2016 /PRNewswire/ ... medicine company with the first pluripotent stem cell-derived ... 1 diabetes in clinical-stage development, today announced that ... Janssen Pharmaceutical Companies of Johnson & Johnson, have ... BetaLogics group into ViaCyte.  The agreement provides ViaCyte ...
(Date:2/3/2016)... NEW BRUNSWICK, N.J. , Feb. 3, 2016 ... 30 grants totaling more than $1 million for ... who are working on health-related research that demonstrates ... , this round of funding for the New ... available for faculty members at these educational institutions— ...
(Date:2/3/2016)... 2016  Silk Therapeutics, Inc., today announced the closing of ... now raised a total of $10.25 million in Series A ... Series A2 round was led by existing investor The Kraft ... from new investors Lear Corporation and Highland Consumer Partners, as ... ; Richard Sackler , MD, with Summer Road, LLC; ...
Breaking Biology Technology:
(Date:2/2/2016)... YORK , Feb. 2, 2016 ... of the bioinformatic market by reviewing the recent ... enabled tools that drive the field forward. Includes ... to: Identify the challenges and opportunities that ... providers and software solution developers, as well as ...
(Date:2/2/2016)... Feb. 2, 2016  Based on its recent ... Sullivan recognizes US-based Intelligent Retinal Imaging Systems (IRIS) ... Award for New Product Innovation. IRIS, a prominent ... North America , is poised to set ... diabetic retinopathy market. The IRIS technology presents superior ...
(Date:1/28/2016)... Synaptics (NASDAQ: SYNA ), a leading developer of ... ended December 31, 2015. --> ... increased 2 percent compared to the comparable quarter last year to ... was $35.0 million, or $0.93 per diluted share. ... first quarter of fiscal 2016 grew 9 percent over the prior ...
Breaking Biology News(10 mins):